KFDA to maker public screening review of clinical trial protocol

Published: 2008-12-26 06:58:00

Updated: 2008-12-26 06:58:00

The Korea Food and Drug Administration unveiled its plan to disclose its screening review concerning protocol, safety and efficacy of drugs, etc. and specification & analytical methods in its web site from next year.

The KFDA said that this will provide transparency into its screening of drug ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK